Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q2 2022 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's size. The transcript shows progress: BlueWalker 3 delivered, launch planned, agreements with MNOs representing 1.8 billion subscribers, Nokia partnership, etc. But does management explicitly state that current activity is disproportionately large relative to the company's small size? They mention "strong progress" and "business momentum" but not a direct contrast. They talk about capital needs for 20 satellites, but that's future. The question asks about RIGHT NOW. Management says they have agreements with MNOs representing 1.8 billion subscribers, which is huge, but they don't explicitly say "we are small and this is large relative to us." They do mention "we have reached more than 1.8 billion subscribers that we can access through agreements" - that's a large number but not contrasted with company size. Also, they talk about raising capital, but that's not a disproportion. The key is whether management conveys that current activity is large relative to the company's smallness. They don't explicitly say that. They mention "we are building the first and only global cellular broadband network" but that's aspirational. The transcript has no explicit statement like "our current commitments are huge compared to our size." So answer NO. But let's check: They say "we have added three new operators... reached more than 1.8 billion subscribers" - that's a big number, but they don't say "this is large relative to our small company." They also mention "we have achieved an agreement to sell a majority ownership or NanoAvionika" - that's a divestiture. The Nokia agreement is a partnership. None of these are described as disproportionately large relative to the company's current size. The company is still pre-revenue, but they don't frame it that way. So NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.